FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566079085> ?p ?o ?g. }

• W2566079085 endingPage "432" @default.
• W2566079085 startingPage "423" @default.
• W2566079085 abstract "BackgroundA few other studies have reported the effects of anatomical and technical factors on clinical outcomes of carotid artery stenting (CAS). This study analyzed the effect of these factors on perioperative stroke/myocardial infarction/death after CAS.MethodsThis was a retrospective analysis of prospectively collected data of 409 of 456 patients who underwent CAS during the study period. A logistic regression analysis was used to determine the effects of anatomical and technical factors on perioperative stroke, death, and myocardial infarction (major adverse events [MAEs]).ResultsThe MAE rate for the entire series was 4.7% (19 of 409), and the stroke rate was 2.2% (9 of 409). The stroke rate for asymptomatic patients was 0.46% (1 of 218; P = .01). The MAE rates for patients with transient ischemic attack (TIA) were 7% (11 of 158) vs 3.2% (8 of 251) for other indications (P = .077). The stroke rates for heavily calcified lesions were 6.3% (3 of 48) vs 1.2% (4 of 332) for mildly calcified/noncalcified lesions (P = .046). Differences in stroke and MAE rates regarding other anatomical features were not significant. The stroke rate for patients with percutaneous transluminal angioplasty (PTA) before embolic protection device (EPD) insertion was 9.1% (2 of 22) vs 1.8% (7 of 387) for patients without (P = .07) and 2.6% (9 of 341) for patients with poststenting PTA vs 0% (0 of 68) for patients without. The MAE rate for patients with poststenting PTA was 5.6% (19 of 341) vs 0% (0 of 68) for patients without (P = .0536). The MAE rate for patients with the ACCUNET (Abbott, Abbott Park, Ill) EPD was 1.9% (3 of 158) vs 6.7% (16 of 240) for others (P = .029). The differences between stroke and MAE rates for other technical features were not significant. A regression analysis showed that the odds ratio for stroke was 0.1 (P = .031) for asymptomatic indications, 13.7 (P = .014) for TIA indications, 6.1 (P = .0303) for PTA performed before EPD insertion, 1.7 for PTA performed before stenting, and 5.4 (P = .0315) for heavily calcified lesions. The MAE odds ratio was 0.46 (P = .0858) for asymptomatic indications, 2.1 for PTAs performed before EPD insertion, 2.2 for poststent PTAs, and 2.2 (P = .1888) for heavily calcified lesions. A multivariate analysis showed that patients with TIA had an odds ratio of stroke of 11.05 (P = .029). Patients with PTAs performed before EPD insertion had an OR of 6.15 (P = .062). Patients with heavily calcified lesions had an odds ratio of stroke of 4.25 (P = .0871). The MAE odds ratio for ACCUNET vs others was 0.27 (P = .0389).ConclusionsCalcific lesions and PTA before EPD insertion or after stenting were associated with higher stroke or MAE rates, or both. The ACCUNET EPD was associated with lower MAE rates. There was no correlation between other anatomical/technical variables and CAS outcome." @default.
• W2566079085 created "2017-01-06" @default.
• W2566079085 creator A5009677706 @default.
• W2566079085 creator A5013973748 @default.
• W2566079085 creator A5031327487 @default.
• W2566079085 creator A5036350290 @default.
• W2566079085 creator A5061921420 @default.
• W2566079085 creator A5063409417 @default.
• W2566079085 creator A5072225057 @default.
• W2566079085 creator A5090164067 @default.
• W2566079085 date "2017-08-01" @default.
• W2566079085 modified "2023-09-29" @default.
• W2566079085 title "Anatomical and technical predictors of perioperative clinical outcomes after carotid artery stenting" @default.
• W2566079085 cites W1484596336 @default.
• W2566079085 cites W154941835 @default.
• W2566079085 cites W1847154865 @default.
• W2566079085 cites W1955664145 @default.
• W2566079085 cites W1965666565 @default.
• W2566079085 cites W1989579780 @default.
• W2566079085 cites W1997960985 @default.
• W2566079085 cites W2002878765 @default.
• W2566079085 cites W2031636424 @default.
• W2566079085 cites W2036301547 @default.
• W2566079085 cites W2038169486 @default.
• W2566079085 cites W2058537614 @default.
• W2566079085 cites W2092501962 @default.
• W2566079085 cites W2100194095 @default.
• W2566079085 cites W2102572407 @default.
• W2566079085 cites W2105663338 @default.
• W2566079085 cites W2107645482 @default.
• W2566079085 cites W2122528416 @default.
• W2566079085 cites W2126411494 @default.
• W2566079085 cites W2128040526 @default.
• W2566079085 cites W2167248641 @default.
• W2566079085 cites W2168729202 @default.
• W2566079085 cites W2180989917 @default.
• W2566079085 doi "https://doi.org/10.1016/j.jvs.2017.02.057" @default.
• W2566079085 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5556906" @default.
• W2566079085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28559171" @default.
• W2566079085 hasPublicationYear "2017" @default.
• W2566079085 type Work @default.
• W2566079085 sameAs 2566079085 @default.
• W2566079085 citedByCount "21" @default.
• W2566079085 countsByYear W25660790852017 @default.
• W2566079085 countsByYear W25660790852018 @default.
• W2566079085 countsByYear W25660790852019 @default.
• W2566079085 countsByYear W25660790852020 @default.
• W2566079085 countsByYear W25660790852021 @default.
• W2566079085 countsByYear W25660790852022 @default.
• W2566079085 countsByYear W25660790852023 @default.
• W2566079085 crossrefType "journal-article" @default.
• W2566079085 hasAuthorship W2566079085A5009677706 @default.
• W2566079085 hasAuthorship W2566079085A5013973748 @default.
• W2566079085 hasAuthorship W2566079085A5031327487 @default.
• W2566079085 hasAuthorship W2566079085A5036350290 @default.
• W2566079085 hasAuthorship W2566079085A5061921420 @default.
• W2566079085 hasAuthorship W2566079085A5063409417 @default.
• W2566079085 hasAuthorship W2566079085A5072225057 @default.
• W2566079085 hasAuthorship W2566079085A5090164067 @default.
• W2566079085 hasBestOaLocation W25660790851 @default.
• W2566079085 hasConcept C126322002 @default.
• W2566079085 hasConcept C127413603 @default.
• W2566079085 hasConcept C141071460 @default.
• W2566079085 hasConcept C164705383 @default.
• W2566079085 hasConcept C179755657 @default.
• W2566079085 hasConcept C2777798775 @default.
• W2566079085 hasConcept C2777910003 @default.
• W2566079085 hasConcept C2779169563 @default.
• W2566079085 hasConcept C2780326628 @default.
• W2566079085 hasConcept C2780645631 @default.
• W2566079085 hasConcept C2781068581 @default.
• W2566079085 hasConcept C2987047532 @default.
• W2566079085 hasConcept C31174226 @default.
• W2566079085 hasConcept C500558357 @default.
• W2566079085 hasConcept C71924100 @default.
• W2566079085 hasConcept C78519656 @default.
• W2566079085 hasConceptScore W2566079085C126322002 @default.
• W2566079085 hasConceptScore W2566079085C127413603 @default.
• W2566079085 hasConceptScore W2566079085C141071460 @default.
• W2566079085 hasConceptScore W2566079085C164705383 @default.
• W2566079085 hasConceptScore W2566079085C179755657 @default.
• W2566079085 hasConceptScore W2566079085C2777798775 @default.
• W2566079085 hasConceptScore W2566079085C2777910003 @default.
• W2566079085 hasConceptScore W2566079085C2779169563 @default.
• W2566079085 hasConceptScore W2566079085C2780326628 @default.
• W2566079085 hasConceptScore W2566079085C2780645631 @default.
• W2566079085 hasConceptScore W2566079085C2781068581 @default.
• W2566079085 hasConceptScore W2566079085C2987047532 @default.
• W2566079085 hasConceptScore W2566079085C31174226 @default.
• W2566079085 hasConceptScore W2566079085C500558357 @default.
• W2566079085 hasConceptScore W2566079085C71924100 @default.
• W2566079085 hasConceptScore W2566079085C78519656 @default.
• W2566079085 hasIssue "2" @default.
• W2566079085 hasLocation W25660790851 @default.
• W2566079085 hasLocation W25660790852 @default.
• W2566079085 hasLocation W25660790853 @default.
• W2566079085 hasLocation W25660790854 @default.
• W2566079085 hasLocation W25660790855 @default.

• next